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CASE REPORT
Expressive Aphasia as a Presentation of
Encephalitis with Bartonella henselae Infection
in an Immunocompetent Adult
Carla B. Marienfeld, MDa*; Daniel B. DiCapua, MDb; Gordon K.
Sze, MDc; and Jonathan M. Goldstein, MDb
Departments of aPsychiatry, bNeurology, and cDiagnostic Radiology, Yale University
School of Medicine, New Haven, Connecticut
Objective: To show the first clinically reported case of Cat Scratch Disease (CSD†) pre-
senting as a focal neurologic deficit in an immunocompetent adult.
Patient: 59-year-old male with a history of a previous stroke.
Results: Examination showed an expressive aphasia, word substitution errors, and impaired
repetition.Ahead CT and MRI showed no acute changes. The EEG findings were non-focal
and did not show any epileptiform activity. The patient had a history of contact with stray kit-
tens and previous axillary lymphadenopathy. Bartonella henselae serology titers were IgG
positive 1:1024 (< 64) and IgM positive 1:20 (< 16). After antibiotic administration, the pa-
tient’s symptoms and aphasia resolved.
Conclusions: Focal presentations concerning for stroke or partial seizure activity may have
underlying infectious etiology. We recommend consideration of CSD in the differential diag-
nosis of any adult with a history of lymphadenopathy, fever, and recent contact with a cat
who presents with neurologic complications.
INTRODUCTION
Bartonella henselae is the primary
cause of Cat Scratch Disease (CSD) [1].
CSD occurs predominantly in the fall and
winter months. Regional lymphadenopathy
is noted in 85 percent of patients, most
commonly in the neck, axilla, and inguinal
region [2]. Typically, the disease is benign
and self-limited with an associated fever
usually occurring one to three weeks after a
scratch, bite, or lick from a kitten [3,4]. In
immunocompetent patients, the disease is
usually self-limited with rare serious com-
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of Psychiatry, Yale University School of Medicine, 300 George Street, Suite 901, New
Haven, CT 06511; Tele: 203-974-7855; E-mail: carla.marienfeld@yale.edu.
†Abbreviations: CSD, cat scratch disease.
Keywords: Bartonella henselae, expressive aphasia, neurologic complications, en-
cephalopathy, antibioticsplications and often no need for antibiotics
[1,5]. Diagnosis is usually based on sero-
logic tests used in the appropriate clinical
setting, though PCR of tissue specimens is
sometimes helpful [6,7].
CASE
A 59-year-old man presented with the
sudden onset of speech difficulties. He re-
ported no other associated symptoms such
as headache, dysarthria, dysphagia, weak-
ness, paresthesias, or difficulty understand-
ing speech. Additional history was
remarkable for a left frontal stroke in March
2007 that presented with mutism and no
other deficits. He had recently adopted sev-
eral stray kittens.Ten days prior to presenta-
tion, he had a skin infection that progressed
to right axillary lymphadenopathy, for which
he received a five-day course of doxycy-
cline.
The initial examination, two hours after
the onset of speech difficulties, revealed an
afebrile man with a painless 4mm erythema-
tous papule with a central scab on his right
forearm. His neurologic exam was remark-
able for an expressive aphasia, word substi-
tution errors, and impaired repetition.Ahead
CT in the emergency department showed a
low-density lesion in the region of the left
insula, with well-defined borders and no
mass effect (Figure 1).The following morn-
ing, the patient had an MRI of the brain that
showed his prior stroke but no areas of acute
ischemia (Figures 2a-e). An EEG showed
moderate generalized slowing with no
epileptiform activity.
The aphasia fluctuated between making
paraphasic errors and a frank expressive
aphasia, and he was becoming more con-
fused. Shortly after his EEG and approxi-
mately18hoursfromtheonsetofsymptoms,
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Figure 1. CT scan without contrast. Low-
density lesion in the region of the left in-
sula, with well-defined borders and no
mass effect.
Figures 2a (left) and b. Axial and coronal
flair sequences. Hyperintensity centered
on the insula, without mass effect.
Figure 2c. Diffu-
sion-weighted
image. No acute
findings; specifi-
cally, no sugges-
tion of recent
infarction.
Figures 2d (left) and e. Pre- and post-con-
trast T1-weighted axial scans. No enhance-
ment in the region noted to be abnormal on
the FLAIR sequences. The entire series of
images, including the FLAIR, diffusion, and
post-contrast images, are not consistent with
an acute or subacute infarction.thepatienthadawitnessedgeneralizedtonic-
clonic seizure. A lumbar puncture showed
133 red blood cells (RBC)/microliter (0
cells/microliter) in tube 1 with no white
blood cells (WBC). There were no RBCs in
tube 4 with one WBC/microliter (normal 0-
5 cells/microliter). The CSF glucose was
60mg/dl (40-70mg/dl), and the protein was
64mg/dl (15-45mg/dl). HSV, VZV, En-
terovirusPCR,WestNileandLymeantibod-
ies, as well as VDRL and CSF culture, were
all negative or absent.
The following morning the patient was
aphasic, febrile, had an elevatedWBC count
to 12,000/microliter, and his level of alert-
ness worsened. A repeat EEG showed non-
focal findings, including a moderate
generalized slowing and frontal intermittent
polymorphic delta slowing with no epilepti-
form activity. Considering the history of
stray kittens in his home, a suspicious skin
lesion, and previous axillary lymphadenopa-
thy, the possibility of Bartonella henselae
infection was raised. At approximately 48
hours from symptom onset, B. henselae
serology studies were sent, and the patient
was given one dose ofAzithromycin 500mg
IV. The next morning, the patient’s symp-
toms and aphasia had resolved. He was
switched to doxycycline and rifampin, based
on CSF penetration profiles, and discharged
home with a 14-day course of the above an-
tibiotics. B. henselae titers were reported as
IgG positive 1:1024 (nl < 64) and IgM pos-
itive 1:20 (nl < 16). Follow-up imaging sev-
eral weeks later showed no interval change
(Figures 3 a-e).
Today, the patient has resumed his oc-
cupation as a musician, singer, and song-
writer. He is teaching classes and currently
intherecordingstudioworkingonanalbum.
DISCUSSION
Our patient is the first adult case of
serologically confirmed B. henselae infec-
tion presenting with a recurring expressive
aphasia that we have encountered. The pa-
tient had a prior stroke in a region associated
with speech apraxias and expressive
aphasias, and he presented with mutism at
that time. Several studies suggest that the
blood brain barrier is dysfunctional in re-
gions of prior infarct, which provides a po-
tential portal of entry to the central nervous
system [8,9]. Entry of B. henselae and in-
flammatory mediators at this site could ex-
plain initial symptoms of recrudescence of
his previous focal deficit. However, while
initially presenting with an expressive apha-
sia, he went on to develop several symptoms
inconsistent with a purely ischemic cause or
solely recrudescence of a prior stroke.While
epileptiform phenomenon can develop in the
setting of old cortical ischemic lesions, this
is less likely given the non-focal and non-
epileptiform EEG findings, the waxing and
waning consciousness in the setting of a
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Figures 3a (left) and b. Follow-up axial
and coronal FLAIR sequences. Previ-
ously seen abnormality in the left insula,
with no interval change.
Figures 3c-e
(counter clockwise).
Diffusion-weighted
image and T1-
weighted image
pre- and post-con-
trast. No interval
change; no enhance-
ment seen post-con-
trast to suggest a
subacute process.febrile patient with an elevatedWBC count,
and the recent exposure history. CSD en-
cephalopathy was considered more likely.
Focal neurologic presentations in a popula-
tion this age often prompt concern for
stroke.When this has been thoroughly eval-
uated, it is important to consider that sys-
temic infections such as CSD in the proper
clinical setting also can present with focal
neurologic symptoms.
Most commonly, CSD is diagnosed in
patients younger than 21 [10]; in one study,
79.2 percent were younger than 18 [2]. The
majority of reports involving neurologic pre-
sentations of CSD are from the pediatric lit-
erature. In one report, roughly 12 percent
had neurologic complications [4], and other
reports include severe encephalopathy [11],
status epilepticus [12], anti-epileptic drug re-
sistant seizures [11,13], recurrent status
epilepticus and prolonged encephalopathy
with hemiparesis and chorea [13], pleural ef-
fusions and encephalopathy [14], fatal
meningitis and encephalitis [15], fatal dis-
seminated systemic disease and encephalitis
[16], and acute hemiplegia [17]. There has
been one report of an adolescent boy whose
CSD encephalopathy presented with acute-
onset, self-resolving, recurrent expressive
aphasia [18].
Acomprehensive look at the neurologic
complications of B. henselae since 1995 re-
portedthatencephalopathy,inparticular,was
noted, though there have been associations
with aseptic meningitis and dementia in pa-
tients co-infected with human immunodefi-
ciency virus [19]. More recent reports
describe MRI changes associated with CSD
neurologic manifestations [17,20,21,22].
Largerstudiesestimatebetween0.17percent
to2percentofpatientsdevelopencephalopa-
thy [3,23]. Over the past two decades, there
have been several case reports of CSD with
encephalopathy or meningoencephalitis and
status epilepticus [13,24-29]. Such reports
have prompted recommendations for the
consideration of CSD in the differential di-
agnosis of any previously healthy adult pre-
senting with neurologic complications who
hasahistoryoflymphadenopathy,especially
if he owns a cat [1]. One study showed en-
cephalopathy in 61 of 76 patients with neu-
rologic complications of CSD, with 15
showing cranial or peripheral nerve involve-
ment.Ofthesepatients,78percentrecovered
within one to 12 weeks, and 100 percent re-
covered within one year, with roughly 50
percent receiving antibiotics. None had any
neurologic sequelae [30].
Our patient responded to antibiotics
rapidly. The self-limited form of CSD is
often unaffected by antibiotic treatment [3].
With severe or persistent CSD infection,
several antibiotics are effective, including
erythromycin and doxycycline [1]. While
there is little evidence based treatment for
neurologic disease of CSD, expert opinion
recommends a combination of doxycycline
plus rifampin for 10 to 14 days. Most serious
and potentially life-threatening infections re-
spond well to antibiotic therapy [1].
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